SHAYANKI LAHIRI

Dr. SHAYANKI LAHIRI

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
MMMaphori Maliehe
Maphori Maliehe
'N'Mathope Ntoi
'Mathope Ntoi
SHAYANKI LAHIRISHAYANKI LAHIRI
SHAYANKI LAHIRI
OFOlufemi Folorunso
Olufemi Folorunso
AOAdepemi Ogundeji
Adepemi Ogundeji
OSOlihile M. Sebolai
Olihile M. Sebolai
The ability of microorganisms to colonise and display an intracellular lifestyle within a host body increases their fitness to survive and avoid extinction. This host–pathogen association drives microbial evolution, as such organisms are under selective pressure and can become more pathogenic. Some of these microorganisms can quickly spread through the environment via transmission. The non-transmittable fungal pathogens, such as Cryptococcus, probably return into the environment upon decomposition of the infected host. This review analyses whether re-entry of the pathogen into the environment causes restoration of its non-pathogenic state or whether environmental factors and parameters assist them in maintaining pathogenesis. Cryptococcus (C.) neoformans is therefore used as a model organism to evaluate the impact of environmental stress factors that aid the survival and pathogenesis of C. neoformans intracellularly and extracellularly.

1 April 2020 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
SMSayani Maji
Sayani Maji
NMNetravathi Manjunath
Netravathi Manjunath
VBVeenakumari H. Bahubali
Veenakumari H. Bahubali
RSRajeswari Shome
Rajeswari Shome
PMPALANIAPPAN MARIMUTHU
PALANIAPPAN MARIMUTHU
NCNagarathna Chandrashekar
Nagarathna Chandrashekar

23 July 2017 in Mycoses
Verified
Journal Article
Closed access
SHAYANKI LAHIRISHAYANKI LAHIRI
SHAYANKI LAHIRI
VBVeenakumari H. Bahubali
Veenakumari H. Bahubali
NMNetravathi Manjunath
Netravathi Manjunath
ASAarthi Swaminathan
Aarthi Swaminathan
SMSayani Maji
Sayani Maji
NCNagarathna Chandrashekar
Nagarathna Chandrashekar

3 October 2019 in Medical Mycology
Verified
Journal Article
Closed access
SHAYANKI LAHIRISHAYANKI LAHIRI
SHAYANKI LAHIRI
NMNetravathi Manjunath
Netravathi Manjunath
MBMaya Bhat
Maya Bhat
FHFerry Hagen
Ferry Hagen
VBVeenakumari H Bahubali
Veenakumari H Bahubali
NCNagarathna Chandrashekar
Nagarathna Chandrashekar
In the last two decades, central nervous system (CNS) cryptococcosis (CNSc) has emerged as a major opportunistic infection in the immunocompromised population of India. We have analyzed the clinical features of CNSc and epidemiology of Cryptococcus neoformans and Cryptococcus gattii. A total of 160 clinical isolates of C. neoformans/gattii recovered from CNSc patients were analyzed. The origin, clinical parameters, and imaging features of the patients were recorded, and clinical parameters were analyzed based on their human immunodeficiency virus (HIV) status and infecting species, namely, C. neoformans or C. gattii. Serotypes and mating types of the isolates were determined. Molecular typing was performed by polymerase chain reaction (PCR) fingerprinting using M13 microsatellite primer (GTG)5, and multilocus sequence typing (MLST). Majority of the patients were from Bangalore Urban, Karnataka. Among 160 cases 128 (80%) were HIV seropositive, and 32 (20%) were HIV negative. Middle-aged males (36–55 years) were highly affected. There were statistically significant differences in the clinical manifestations, imaging and CSF parameters of HIV coinfected and noninfected cases, whereas limited differences were observed in these parameters in the cases infected with C. neoformans and C. gattii. We identified 80% C. neoformans VNI, 8.75% VNII and 22.5% C. gattii (VGI), 8.75% C. tetragattii (VGIV) among clinical strains. This comprehensive study will contribute toward a better prognosis of CNS cryptococcosis patients during the hospital stay, treatment strategies for HIV coinfected and noninfected cases and will provide the molecular epidemiology of these two pathogenic fungal species in south India, which was unclear in this part of the country.

1 March 2022 in The American Journal of Pathology
Verified
Journal Article
Closed access
STSeagal Teitz-Tennenbaum
Seagal Teitz-Tennenbaum
SVSteven P. Viglianti
Steven P. Viglianti
AJAhmad Jomma
Ahmad Jomma
QPQuentin Palone
Quentin Palone
HAHalia Andrews
Halia Andrews
JOJohn J. Osterholzer
John J. Osterholzer

1 September 2017 in Journal of Medical Mycology
Verified
Journal Article
Closed access
SHAYANKI LAHIRISHAYANKI LAHIRI
SHAYANKI LAHIRI
AMA. Mahadevan
A. Mahadevan
VBV.H. Bahubali
V.H. Bahubali
RBR. Dawn Bharath
R. Dawn Bharath
APA.R. Prabhuraj
A.R. Prabhuraj
NSN. Siddaiah
N. Siddaiah